Treace Medical Concepts, Inc. Common Stock (TMCI) Stock Price

TMCIStock

$4.65−37.16%52W

Market Cap$302.41M

P/E—

PEG Ratio—

Div yield—

Beta1.48

TMCI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)124.11%

Price vs S&P 500 (4W)-2.18%

VGM Score60.49

Book Value / Share (Quarterly)$1.19

P/TBV (Annual)1.95x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)14.47%

Cash Flow / Share (Quarterly)$-0.40

Price vs S&P 500 (YTD)76.97%

Gross Margin (TTM)79.72%

Net Profit Margin (TTM)-29.44%

EPS (TTM)$-0.96

10-Day Avg Trading Volume0.30M

EPS Excl Extra (TTM)$-0.96

Revenue Growth (5Y)29.95%

EPS (Annual)$-0.93

ROI (Annual)-41.28%

Gross Margin (Annual)79.81%

Net Profit Margin (5Y Avg)-26.57%

Cash / Share (Quarterly)$0.80

Revenue Growth QoQ (YoY)-10.22%

ROA (Last FY)-30.96%

Revenue Growth TTM (YoY)-1.66%

EBITD / Share (TTM)$-0.78

ROE (5Y Avg)-49.14%

Operating Margin (TTM)-28.21%

Cash Flow / Share (Annual)$-0.46

P/B Ratio3.80x

P/B Ratio (Quarterly)1.12x

Net Income / Employee (Annual)$-131,100

EV / Revenue (TTM)1.64x

Net Interest Coverage (TTM)-22.20x

ROA (TTM)-31.39%

EPS Incl Extra (Annual)$-0.93

Current Ratio (Annual)4.31x

Quick Ratio (Quarterly)2.38x

3-Month Avg Trading Volume0.63M

52-Week Price Return-37.16%

Revenue / Employee (TTM)$460,700

Tangible BV / Share (Quarterly)$1.09

P/S Ratio (Annual)1.38x

Asset Turnover (Annual)1.12x

52-Week High$7.63

Operating Margin (5Y Avg)-25.25%

EPS Excl Extra (Annual)$-0.93

CapEx CAGR (5Y)66.07%

26-Week Price Return136.04%

Quick Ratio (Annual)2.95x

13-Week Price Return50.97%

Total Debt / Equity (Annual)0.64x

Current Ratio (Quarterly)3.58x

Enterprise Value$339.58M

Revenue / Share Growth (5Y)24.22%

Asset Turnover (TTM)1.07x

Revenue / Employee (Annual)$472,600

Inventory Turnover (Annual)1.14x

Pretax Margin (Annual)-27.74%

Cash / Share (Annual)$0.76

3-Month Return Std Dev85.91%

Gross Margin (5Y Avg)80.63%

Net Income / Employee (TTM)$-135,600

ROE (Last FY)-67.56%

Net Interest Coverage (Annual)-18.43x

EPS Basic Excl Extra (Annual)$-0.93

Receivables Turnover (TTM)6.75x

Total Debt / Equity (Quarterly)0.72x

EPS Incl Extra (TTM)$-0.96

Receivables Turnover (Annual)5.13x

ROI (TTM)-42.64%

P/S Ratio (TTM)1.41x

Pretax Margin (5Y Avg)-26.57%

Revenue / Share (Annual)$3.36

Tangible BV / Share (Annual)$1.25

Price vs S&P 500 (52W)-55.72%

Year-to-Date Return89.80%

5-Day Price Return6.41%

EPS Normalized (Annual)$-0.93

ROA (5Y Avg)-23.57%

Net Profit Margin (Annual)-27.74%

Month-to-Date Return7.89%

Cash Flow / Share (TTM)$-0.73

EBITD / Share (Annual)$-0.73

Operating Margin (Annual)-26.75%

LT Debt / Equity (Annual)0.64x

ROI (5Y Avg)-31.08%

LT Debt / Equity (Quarterly)0.72x

EPS Basic Excl Extra (TTM)$-0.96

P/TBV (Quarterly)1.23x

P/B Ratio (Annual)1.79x

Inventory Turnover (TTM)1.13x

Pretax Margin (TTM)-29.44%

Book Value / Share (Annual)$1.36

Price vs S&P 500 (13W)49.02%

Beta1.48x

Revenue / Share (TTM)$3.21

ROE (TTM)-69.50%

52-Week Low$1.17

vGradeB

gGradeC

mGradeB

vgmGradeB

TMCI Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 7, 2026	-$0.30	-$0.20	+33.30%(+$0.10)
Q1 2026	May 8, 2026	-$0.31	-$0.12	+62.78%(+$0.19)
Q4 2025	Feb 27, 2026	-$0.14	-$0.08	+44.07%(+$0.06)
Q3 2025	Nov 6, 2025	-$0.27	-$0.22	+18.17%(+$0.05)
Q2 2025	Aug 7, 2025	-$0.29	-$0.26	+9.79%(+$0.03)

TMCI Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.50

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
TMCITreace Medical Concepts, Inc. Common Stock	B	C	B	$4.65
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55

About Treace Medical Concepts, Inc. Common Stock

Treace Medical Concepts develops and commercializes the Lapiplasty 3D Bunion Correction procedure, a patented surgical solution for treating bunion deformities. The procedure addresses the underlying cause of bunions across all planes of deformity while enabling patients to return to normal activities quickly. The company markets its devices to surgeons, ambulatory surgery centers, and hospitals in the large and growing orthopedic foot surgery market.